Intervet

Equine Vaccine

ENCEPHALOMYELITIS - INFLUENZA VACCINE

EASTERN AND WESTERN KILLED VIRUS

TETANUS TOXOID

A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin, Eastern and Western Equine Encephalomyelitis Viruses, Equine Influenza Virus subtype A2 including KY93, KY02, and NM2/93 strains and Tetanus Toxoid. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89, and South Africa 03.

INDICATIONS: For vaccination of healthy horses, 6 months of age or older, as an aid in the prevention of Eastern and Western Encephalomyelitis and Tetanus, and as an aid the reduction of virus shedding and control of respiratory disease caused by Equine Influenza Virus. Duration of Immuity (DOI) has been shown to be at least 6 months for Influenza. Foals nursing immune-dams should be vaccinated when maternal antibody levels willl allow active immunization.

DOSE: For primary immunization aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened (10 doses). Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur.

CAUTION: Needle is sharp and may cause injury to self or animals if not handled properly or disposed of properly.

ANTIDOTE: Epinephrine.

Thimerosal added as preservative.

*Adjuvant-Intervet's proprietary technology.

FOR USE IN ANIMALS ONLY

Intervet Inc., Millsboro, DE 19966

1-800-441-8272

www.intervetusa.com

U.S. Vet. License No. 286

NAC No.: 11060492